Portfolio company
Scala Biodesign
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops protein design software for pharmaceutical and chemical organisations to improve the stability and activity of enzymes and therapeutic antibodies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Arzeda
This company develops computational protein design software to create enzymes and chemicals for customers in the food, home care and materials industries.
Zymvol
This company develops computational enzyme discovery and engineering software for industrial clients in the pharmaceutical, chemical and manufacturing sectors.
Provolut
This company develops artificial intelligence software for protein and enzyme engineering to support researchers in the pharmaceutical and industrial biotechnology sectors.
Protillion Biosciences
This company develops a high-throughput protein engineering platform for pharmaceutical partners to accelerate the discovery and optimisation of therapeutic antibodies and binder drugs.
MendelFOLD
This company develops computational protein modelling tools to help pharmaceutical teams and researchers identify drug binding sites and design new medical treatments.
310.ai
This company develops generative artificial intelligence models to design novel proteins and biomolecules for pharmaceutical and biotechnology organisations.
Perlin Bioworks AG
The company develops custom enzymes using computational design and laboratory validation for pharmaceutical and fine-chemical manufacturing firms.
Open Protein
This company provides a no-code machine learning platform for protein engineering and sequence generation to researchers in biotechnology, pharmaceuticals and academia.
